BioSpace News Archive

Business

Consumer genetics pioneer DnaNudge and Imperial College London join forces with Waitrose & Partners for breakthrough diabetes prevention study

First public trial of DnaNudge’s technology has today been launched to study effects of DNA-based food choices for pre-diabetic individuals

October 18, 2018
·
6 min read
Career Advice

8 Questions Not to Ask in the Job Interview

It’s prudent to be aware of certain types of questions that -- while perhaps valid -- just don’t belong in this particular professional encounter and, in fact, could harm your candidacy and reflect negatively on your reputation if asked.

October 18, 2018
·
4 min read
·
Editorial Staff
Drug Development

Innovent Announces First Patient Dosed in a Phase I Clinical Trial of Anti-CTLA-4 Monoclonal Antibody

Innovent Biologics, Inc. announces that the first patient has been dosed in a phase I clinical trial of anti-CTLA-4 (Cytotoxic T Lymphocyte-associated Antigen-4) monoclonal antibody (IBI310) for patients with advanced solid tumors. IBI310 is a fully human monoclonal antibody that blocks CTLA-4.

October 18, 2018
·
4 min read
Drug Development

Novaliq Announces Positive Topline Results for Its CyclASol® Phase 2B/3 Essence Trial in Patients with Dry Eye Disease

The ESSENCE trial met its primary endpoint at 4 weeks and demonstrated superiority of CyclASol® over vehicle in change from baseline on corneal fluorescein staining

October 18, 2018
·
6 min read
Drug Development

GenSight Biologics reports positive 72-week data from REVERSE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)

Clinically meaningful improvement of +15 ETDRS letters in visual acuity of treated eyes at Week 72

October 18, 2018
·
7 min read
Business

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

AELIX Therapeutics will investigate the safety, immunogenicity, and efficacy of AELIX Therapeutics’ HTI vaccine and Gilead´s Toll-Like Receptor 7 agonist vesatolimod (GS-9620) in HIV-infected individuals

October 18, 2018
·
5 min read
Policy

Ascletis’ Ravidasvir NDA Proposed for Priority Review by the CFDA

Ascletis Pharma Inc. announces today the New Drug Application (NDA) of Ravidasvir is on the List of Proposed Priority Review, according to the public notification by the China Food and Drug Administration (CFDA) on Oct 17th, 2018.

October 18, 2018
·
1 min read
Business

Valens announces formation of advisory board

Valens GroWorks Corp. announce that it has formed an advisory board to assist in implementing the Company’s current strategic plans and identify means to capitalize on future growth opportunities.

October 18, 2018
·
5 min read
Biotech Beach

Delta Dental Community Care Foundation awards $131,483 grant to San Ysidro Health

The organization serves over 95,000 patients annually through a network of medical, dental, and behavioral health clinics located across San Diego County.

October 18, 2018
·
2 min read
Business

Former DEA Agent and Inspiration for Netflix’s Narcos Series Announced as Verde Techologies’ Newest Advisory Council Member

COMPANY ALSO RECEIVES PRESTIGIOUS AWARD FOR ITS EFFORTS TO TACKLE THE OPIOID EPIDEMIC

October 18, 2018
·
3 min read